Arix Bioscience (ARIX)

Company name:Arix Bioscience Plc
EPIC:ARIXTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BD045071
Market Segment:SSQ3Share Type:DE
WWW Address: 0.001P
 Price Price Change [%] Bid Offer Open High Low Volume
 129.00 -0.5 [-0.39] 129.00 129.50 129.75 129.75 129.25 212,527
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 166.64 129.18 0.08 96.60 - 1.34 - 208.00 - 66.68

Arix Bioscience Key Figures

Key Figures
(at previous day's close)
Market Cap.166.64m
Shares In Issue129.18m
Prev. Close129.50
PE Ratio1.34 
Dividend Yield-%
EPS - basic96.60p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-5.21p
Return On Equity (ROE)38.41%
Operating Margin26,478.20%
PEG Factor0.00 
EPS Growth Rate279.55%
Dividends PS Growth Rate-%
Net Debt-109.58m
Gross Gearing0.76%
Quick Assets175.74m
Net Working Capital173.50m
Intangibles / Fixed Assets0.26%
Turnover PS0.37p
Pre-Tax Profit PS97.77p
Retained Profit PS97.60p
Cash PS86.77p
Net Cash PS85.04p
Net Tangible Asset Value PS *253.76p
Net Asset Value PS254.07p
Spread0.50 (0.39%) 

Arix Bioscience Balance Sheet

%1$s Balance Sheet

Share Price Performance

Share Price Performance
Sample Period HighLow
1 week134.00129.25
4 weeks135.00119.50
12 weeks140.7566.68
1 year208.0066.68

Share Price Chart (5 years)

Share Price Chart (5 years)

Arix Bioscience Historic Returns

%1$s Historic Returns
Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week133.00-4.00-3.01129.250.11131.10
4 weeks122.506.505.31119.500.19125.05
12 weeks139.00-10.00-7.1966.680.16128.97
26 weeks177.00-48.00-27.1266.680.16144.18
1 year198.00-69.00-34.8566.680.20170.37
3 years175.00-46.00-26.2958.500.12147.41
5 years210.00-81.00-38.5758.500.10155.71

Arix Bioscience Key Management Ratios


Arix Bioscience Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio1.34 
Tobin's Q Ratio 0.62 
Tobin's Q Ratio (excl. intangibles)0.62 
Dividend Yield-%
Market-to-Book Ratio0.51 
Price-to-Pre-Tax Profit PS1.32 
Price-to-Retained Profit PS1.32 
Price-to-Cash Flow PS-24.75 
Price-to-Sales PS349.35 
Price-to-Net Tangible Asset Value PS0.51 
Price-to-Cash PS1.49 
Net Working Capital PS134.31 
Price Pct to Working Capital PS0.96%
Earnings Yield74.88%
Average PE2.69 
Years in average2 
PE to PE average49.69%

Arix Bioscience Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio0.08%
Debt-to-Equity Ratio0.00 
Debt-to-Equity Ratio (excl. Intgbl)0.00 
Debt-to-Equity Market Value0.00 
Net Gearing-33.14%
Net Gearing (excl. Intangibles)-33.18%
Gross Gearing0.76%
Gross Gearing (excl. Intangibles)0.76%
Gearing Under 1 Year0.68%
Gearing Under 1 Year (excl. Intgbl)0.68%
(Liquidity Ratios)
Net Working Capital to Total Assets52.46%
Current Ratio78.63 
Quick Ratio (Acid Test)78.63 
Liquidity Ratio50.15 
Cash & Equiv/Current Assets63.78%
(Solvency Ratios)
Enterprise Value54.82m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.02 
Total Debt/Sales5.25 
Total Debt/Pre-Tax Profit0.02 
Total Debt2.50m
Total Debt/Net Current Assets0.01%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth44.37%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)

Arix Bioscience Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)38.45%
Return On Assets (ROA)46.70%
Net Profit Margin26,431.03%
Assets Turnover0.00 
Return On Equity (ROE)38.41%
Return On Investment (ROI)47.50%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio47.55%
Net Income Of Revenues26,431.03%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.00 
Current Assets Turnover0.00 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales565.96 
Debt Collection Period24,249.93Days

Arix Bioscience Dividends

Sorry No Data Available

Arix Bioscience Fundamentals

Profit and Loss Account
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
pre tax profit-7.69-414.11%42.763,219.95%-75.57-126.30-m
attributable profit-8.61-463.76%38.152,872.52%-69.87-126.08-m
retained profit-8.61-463.76%38.152,872.52%-69.87-126.08-m
eps - basic (p)-0.11 32.10 -53.80 96.60 
eps - diluted (p)-0.11 29.70 -53.80 88.60 
dividends per share- - - - 

Arix Bioscience Balance Sheet

Balance Sheet
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
fixed assets fixed assets0.520.35%0.310.11%0.160.08%0.050.01%m
intangibles intangibles2.061.37%1.770.63%1.030.49%0.400.12%m
fixed investments fixed investments71.3347.52%183.9865.84%152.2972.79%154.5246.72%m
current assets - other current assets - other--%--%--%1.380.42%m
stocks stocks--%--%--%--%m
debtors debtors1.270.84%2.170.78%1.110.53%62.2818.83%m
cash & securities cash & securities74.9449.92%91.2232.64%54.6426.12%112.0933.89%m
creditors - short creditors - short3.672.44%9.283.32%6.843.27%2.240.68%m
creditors - long creditors - long--%--%0.270.13%0.270.08%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves146.4497.56%270.1796.68%202.1196.60%328.2199.24%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Arix Bioscience Cash Flow Statement

%1$s Cash Flow Statement
31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF-8.78-11.06-8.47-6.73m
Pre-Financing CF-59.03-126.5025.6659.59m
Retained CF46.05-44.2524.6859.59m

Arix Bioscience Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Arix Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20220120 17:32:44